PLK1 and pancreatic neoplasm: In this study, we developed a site-specific RNA demethylation system by applying the CRISPR-Cas9 system9 and examined the various changes in pancreatic cancer cells by demethylating the PLK1 3′UTR site with FTO, increasing cell death with an increase in the S–G2–M phase.